12/22
10:03 am
nrxs
NeurAxis (NASDAQ:NRXS) had its "buy" rating reaffirmed by analysts at Craig Hallum.
High
Report
NeurAxis (NASDAQ:NRXS) had its "buy" rating reaffirmed by analysts at Craig Hallum.
12/19
08:35 am
nrxs
NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives [Yahoo! Finance]
Medium
Report
NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives [Yahoo! Finance]
12/19
08:00 am
nrxs
NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives
Low
Report
NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives
12/1
09:44 am
nrxs
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain [Yahoo! Finance]
Medium
Report
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain [Yahoo! Finance]
12/1
07:00 am
nrxs
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain
Medium
Report
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain
11/12
08:00 am
nrxs
NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
Medium
Report
NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
11/11
07:00 am
nrxs
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
Medium
Report
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
11/4
08:30 am
nrxs
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
Low
Report
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
10/24
08:00 am
nrxs
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
High
Report
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population